149 related articles for article (PubMed ID: 16930710)
1. Virus-epitope vaccine design: informatic matching the HLA-I polymorphism to the virus genome.
Vider-Shalit T; Raffaeli S; Louzoun Y
Mol Immunol; 2007 Feb; 44(6):1253-61. PubMed ID: 16930710
[TBL] [Abstract][Full Text] [Related]
2. Universal peptide vaccines - optimal peptide vaccine design based on viral sequence conservation.
Toussaint NC; Maman Y; Kohlbacher O; Louzoun Y
Vaccine; 2011 Nov; 29(47):8745-53. PubMed ID: 21875632
[TBL] [Abstract][Full Text] [Related]
3. T-cell epitope repertoire as predicted from human and viral genomes.
Louzoun Y; Vider T; Weigert M
Mol Immunol; 2006 Feb; 43(6):559-69. PubMed ID: 15927255
[TBL] [Abstract][Full Text] [Related]
4. Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.
Schiewe AJ; Haworth IS
J Mol Graph Model; 2007 Oct; 26(3):667-75. PubMed ID: 17493854
[TBL] [Abstract][Full Text] [Related]
5. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection.
Gaudieri S; Rauch A; Park LP; Freitas E; Herrmann S; Jeffrey G; Cheng W; Pfafferott K; Naidoo K; Chapman R; Battegay M; Weber R; Telenti A; Furrer H; James I; Lucas M; Mallal SA
J Virol; 2006 Nov; 80(22):11094-104. PubMed ID: 17071929
[TBL] [Abstract][Full Text] [Related]
6. Predicting the affinity of epitope-peptides with class I MHC molecule HLA-A*0201: an application of amino acid-based peptide prediction.
Du QS; Wei YT; Pang ZW; Chou KC; Huang RB
Protein Eng Des Sel; 2007 Sep; 20(9):417-23. PubMed ID: 17681974
[TBL] [Abstract][Full Text] [Related]
7. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a multivalent, multiepitope vaccine construct.
Otvos L
Methods Mol Biol; 2008; 494():263-73. PubMed ID: 18726579
[TBL] [Abstract][Full Text] [Related]
9. An avian influenza vaccine for humans targeting the polymerase B2 protein inside the capsid instead of hemagglutinin or neuramidase on the virus surface.
Gillis JS
Med Hypotheses; 2006; 66(5):975-7. PubMed ID: 16403603
[TBL] [Abstract][Full Text] [Related]
10. Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach.
De Groot AS; Jesdale B; Martin W; Saint Aubin C; Sbai H; Bosma A; Lieberman J; Skowron G; Mansourati F; Mayer KH
Vaccine; 2003 Oct; 21(27-30):4486-504. PubMed ID: 14505932
[TBL] [Abstract][Full Text] [Related]
11. Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes.
Houghton CS; Engelhorn ME; Liu C; Song D; Gregor P; Livingston PO; Orlandi F; Wolchok JD; McCracken J; Houghton AN; Guevara-Patiño JA
Vaccine; 2007 Jul; 25(29):5330-42. PubMed ID: 17570567
[TBL] [Abstract][Full Text] [Related]
12. Broad Spectrum Peptide Vaccine Design Against Hepatitis C Virus.
Dewi SK; Ali S; Prasasty VD
Curr Comput Aided Drug Des; 2019; 15(2):120-135. PubMed ID: 30280672
[TBL] [Abstract][Full Text] [Related]
13. Peptide based vaccine design: synthesis and immunological characterization of branched polypeptide conjugates comprising the 276-284 immunodominant epitope of HSV-1 glycoprotein D.
Mezo G; Dalmadi B; Mucsi I; Bosze S; Rajnavölgyl E; Hudecz F
J Pept Sci; 2002 Mar; 8(3):107-17. PubMed ID: 11931583
[TBL] [Abstract][Full Text] [Related]
14. Identifying cytotoxic T cell epitopes from genomic and proteomic information: "The human MHC project.".
Lauemøller SL; Kesmir C; Corbet SL; Fomsgaard A; Holm A; Claesson MH; Brunak S; Buus S
Rev Immunogenet; 2000; 2(4):477-91. PubMed ID: 12361091
[TBL] [Abstract][Full Text] [Related]
15. Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes.
Grollo L; Torresi J; Drummer H; Zeng W; Williamson N; Jackson DC
Antivir Ther; 2006; 11(8):1005-14. PubMed ID: 17302370
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients.
Fonseca SG; Coutinho-Silva A; Fonseca LA; Segurado AC; Moraes SL; Rodrigues H; Hammer J; Kallás EG; Sidney J; Sette A; Kalil J; Cunha-Neto E
AIDS; 2006 Nov; 20(18):2263-73. PubMed ID: 17117012
[TBL] [Abstract][Full Text] [Related]
17. CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.
Wang M; Lamberth K; Harndahl M; Røder G; Stryhn A; Larsen MV; Nielsen M; Lundegaard C; Tang ST; Dziegiel MH; Rosenkvist J; Pedersen AE; Buus S; Claesson MH; Lund O
Vaccine; 2007 Apr; 25(15):2823-31. PubMed ID: 17254671
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
Jones MA; Hislop AD; Snaith JS
Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
[TBL] [Abstract][Full Text] [Related]
19. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.
Patarroyo ME; Patarroyo MA
Acc Chem Res; 2008 Mar; 41(3):377-86. PubMed ID: 18266328
[TBL] [Abstract][Full Text] [Related]
20. HLA class I epitope discovery in type 1 diabetes.
van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
